Answers are grounded in this paper and cite their sources.
Case series demonstrates complex coagulopathy driven by intravascular clotting and fibrinolysis in acute promyelocytic leukemia, highlighting distinct mechanisms underlying lethal bleeding risks.
Four patients with acute promyelocytic leukemia manifested multiple coagulation abnormalities including hypofibrinogenemia, prolongation of prothrombin and thrombin times, and varying deficiencies of coagulation factors. One of the patients (patient 2) showed rising levels of fibrinogen without changes in other coagulation factors on heparin therapy and demonstrated widespread intravascular coagulation on postmortem examination. Another patient (patient 1) had positive tests for active fibrinolysis and an absolute lack of the usual postmortem thrombi. The current hypotheses of the pathogenesis of the coagulation abnormalities are presented as well as guide to therapeutic management.
No takes yet. Share an insight, caveat, or question.
Joseph J. Rand (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: